12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • Aridis Pharmaceuticals ARDS stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4 million.
  • MyMD Pharmaceuticals MYMD shares increased by 14.32% to $4.55. The company's market cap stands at $171.2 million.
  • Also check out these insider trades in penny stocks
  • Galapagos GLPG shares rose 13.41% to $60.47. The market value of their outstanding shares is at $3.9 billion.
  • SELLAS Life Sciences Gr SLS stock increased by 10.62% to $5.62. The company's market cap stands at $89.2 million.
  • Immix Biopharma IMMX stock increased by 6.76% to $3.79. The market value of their outstanding shares is at $28.7 million.
  • Mainz Biomed MYNZ shares moved upwards by 6.62% to $15.46. The market value of their outstanding shares is at $185.6 million.

Losers

  • Epizyme EPZM stock declined by 26.3% to $1.4 during Thursday's pre-market session. The market value of their outstanding shares is at $145.4 million.
  • Ovid Therapeutics OVID stock decreased by 10.99% to $2.43. The company's market cap stands at $165.4 million.
  • Zymeworks ZYME shares declined by 10.95% to $8.3. The company's market cap stands at $386.3 million.
  • Molecular Partners MOLN stock declined by 7.02% to $27.43. The company's market cap stands at $885.4 million.
  • Chembio Diagnostics CEMI shares decreased by 5.5% to $0.86. The market value of their outstanding shares is at $25.8 million.
  • Vaccinex VCNX stock fell 5.41% to $1.05. The market value of their outstanding shares is at $32.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!